Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~1. Age over 1 month and under 17 years~2. Confirmed diagnosis of COVID-19 infection with the results of real-time PCR~3. That they agreed to participate in the study.~4. That the patient tolerates the enteral route~Exclusion criteria~1. Have received vitamin D in the four weeks prior to hospitalization.

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- cholecalciferol (Vitamin D) (Type: EXPERIMENTAL): Children under 12 months they will be given 1000U and in children over 12 months they will be given 2000U every 24 hours orally during hospitalization
- Control (Type: NO_INTERVENTION): No intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).